Pharma Pulse 10/24/24: Semaglutide Supply Chain & Access Challenges, Challenges in Adopting Novel Therapies & more
The latest news for pharma industry insiders.
Semaglutide Supply Chain & Access Challenges
Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss specific challenges that have arisen in the supply chain for semaglutide and how to ensure that patients continue to have access to essential medications, particularly during shortages.
Challenges in Adopting Novel Therapies
Panelists discuss how implementing novel combination therapies or emerging agents from clinical trials into real-world clinical practice for multiple myeloma faces significant challenges, including managing complex dosing regimens, addressing potential toxicities, ensuring patient adherence, navigating insurance coverage and cost issues, and bridging the gap between highly controlled trial conditions and diverse patient populations encountered in everyday clinical settings
OpenAI Hires Former White House Official as Its Chief Economist
Aaron Chatterji was chief economist at the Commerce Department under President Biden and served on President Obama’s Council of Economic Advisers.
Morehouse School of Medicine with support from Ferring Pharmaceuticals has introduced the FertilityEquity™ e-Learning modules, powered by EngagedMD. This critical initiative is focused on championing equity in fertility care for Black women through education and direct application in clinical practice for healthcare professionals and fertility clinic staff.
Curious about the future of pharma supply chain? Tim McClatchy, Kenco’s VP of Life Sciences, shares insights into the industry's biggest challenges in his latest Pharmaceutical Commerce Magazine article.
#lifesciences #PharmaceuticalCommerce #supplychain #3pl #Kenco
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
